ZFGN を保有するビリオネア

ビリオネア ポートフォリオ内保有比率 保有株数(百万株) % 平均取得コスト 平均取得コスト リターン

ファンダメンタルズ

  • N/A
    株価収益率(PER)

  • 0.0
    利回り(%)

  • 23百万ドル
    発行済み株式数

  • 5229M
    時価総額

News & Insights

ABOUT

ZFGN

Zafgen, Inc., a biopharmaceutical company, focuses on the provision of therapeutics for patients suffering from obesity and obesity-related disorders. Its lead product candidate includes Beloranib, an injection that is in Phase II clinical trials for the treatment of various indications comprisin...

Three Main Takeaways From Soros’ Open-Ed On The Brexit

NEWS

Soros, Druckenmiller among hedgies profiting in market plunge

READ MORE